Burden of cancer trial participation: A qualitative sub-study of the INTERIM feasibility RCT.

This is the first study to highlight the substantial burden faced by patients with advanced melanoma in a clinical trial and factors that may lessen or worsen the burden. Consideration of identified burdens during trial design and execution will reduce the burden experienced by research participants.